I’m not betting on the covid ‘complete’ vaccine. It’s still an extreme long shot, regardless of Joe’s evident enthusiasm. Prove me wrong, NGIO! Instead I’m betting on the the NGIO spinout, and the cancer and swine flu vaccines. Beyond NGIO, i’m betting on the GNBT subsidiary progress that can be made once the funding starts to flow: JMHO... the remote medical platform, Excellagen and Altucel will be the big near term winners for GNBT.